Presenter Biography

Javier Huerta is a student in the MPH Epidemiology program at the OHSU-PSU School of Public Health. He is a research assistant working with Dr. Jennifer Manne-Goehler focused on neglected disease research at Harvard Medical School in Boston, MA. This study expands on his practice experience for the MPH program.

Institution

OHSU

Program/Major

Epidemiology

Degree

MPH

Presentation Type

Poster

Start Date

4-4-2024 1:00 PM

Creative Commons License or Rights Statement

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Persistent Identifier

https://archives.pdx.edu/ds/psu/41983

Subjects

Chagas' disease, Trypanosoma cruzi, Epidemiology, Screening

Abstract

Purpose: Chagas disease (CD), a neglected parasitic infection, affects ~300,000 people in the US. Untreated, CD leads to irreversible cardiac morbidity and death in 20-30% of cases, yet

Methods: After provider and community sessions, 14,354 patients were screened at EBNHC from March 2017 - May 2023, following a prespecified protocol. Confirmed Chagas patients were referred to Boston Medical Center for further evaluation. Using chi-squared tests, we analyze diagnostic uptake and prevalence stratified by demographics. Additionally, we abstracted care continuum barriers from Chagas patients' records.

Results: Per quarter, a median of 572 patients were screened (IQR: 393 – 712). 3.4% of screening tests were positive. After confirmation, the overall prevalence of Chagas in the population was 0.7% (95% CI: 0.6% – 0.9%) with no sex difference. A statistically significant age gradient was observed, with the lowest prevalence observed in(0.0%) and the highest in 40-49 year-olds (0.8%; p=

Conclusion: Given the significant prevalence of Chagas disease in high-risk US communities, increased access to screening, confirmatory testing, and diagnostics is needed. Chagas care by motivated primary care providers is feasible when support for confirmatory testing and care navigation are in place.

Included in

Public Health Commons

Share

COinS
 
Apr 4th, 1:00 PM

Strong Hearts Program: the Results of a Novel Primary-care Based Diagnostic and Referral Program for Chagas Disease in East Boston, MA, USA

Purpose: Chagas disease (CD), a neglected parasitic infection, affects ~300,000 people in the US. Untreated, CD leads to irreversible cardiac morbidity and death in 20-30% of cases, yet

Methods: After provider and community sessions, 14,354 patients were screened at EBNHC from March 2017 - May 2023, following a prespecified protocol. Confirmed Chagas patients were referred to Boston Medical Center for further evaluation. Using chi-squared tests, we analyze diagnostic uptake and prevalence stratified by demographics. Additionally, we abstracted care continuum barriers from Chagas patients' records.

Results: Per quarter, a median of 572 patients were screened (IQR: 393 – 712). 3.4% of screening tests were positive. After confirmation, the overall prevalence of Chagas in the population was 0.7% (95% CI: 0.6% – 0.9%) with no sex difference. A statistically significant age gradient was observed, with the lowest prevalence observed in(0.0%) and the highest in 40-49 year-olds (0.8%; p=

Conclusion: Given the significant prevalence of Chagas disease in high-risk US communities, increased access to screening, confirmatory testing, and diagnostics is needed. Chagas care by motivated primary care providers is feasible when support for confirmatory testing and care navigation are in place.